SOCS3 in liver regeneration and hepatocarcinoma

Joanne Elliott1

  • 1Infection and Immunity Group, Centre for Cancer Research and Cell Biology, School of Biomedical Sciences, Faculty of Medicine, Health and Life Sciences, Queen's University, Whitla Medical Building, Belfast, BT9 7BL, N. Ireland. joanne.elliott@qub.ac.uk

Insights

Suppressors of cytokine signaling 3 (SOCS3) protein is critical for controlling liver cell responses. Loss of SOCS3 in liver cells promotes proliferation and cancer, offering insights into liver regeneration and disease control.

Area of Science:

  • Immunology
  • Hepatology
  • Oncology

Background:

  • Cytokine signaling is regulated by suppressors of cytokine signaling (SOCS) proteins.
  • SOCS protein dysfunction is linked to cancers, hematopoiesis disorders, and autoimmune diseases.
  • SOCS3 plays a key role in modulating cytokine-mediated and neoplastic-proliferative responses in the liver.

Purpose of the Study:

  • To investigate the role of SOCS3 in liver regeneration and hepatocellular carcinoma formation.
  • To elucidate the regulation of pathways involved in liver regeneration.

Main Methods:

  • Generation of hepatocyte-specific Socs3 knockout mice.
  • Analysis of hepatocyte proliferation, survival, and tumor formation in knockout mice.

Main Results:

  • Loss of SOCS3 expression in hepatocytes promotes cell proliferation and survival.
  • Hepatocyte-specific Socs3 knockout mice exhibit increased hepatocellular carcinoma formation.
  • SOCS3 is critical for controlling neoplastic-proliferative responses in the liver.

Conclusions:

  • SOCS3 is a crucial regulator of liver regeneration and hepatocellular carcinoma.
  • Understanding SOCS3 regulation offers potential therapeutic strategies for liver disease and cancer.